almagate has been researched along with Glaucoma, Neovascular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, X; Jia, X | 1 |
| Ducharme, JF; Filippopoulos, T; Krzystolik, MG; Loewenstein, JI | 1 |
2 other study(ies) available for almagate and Glaucoma, Neovascular
| Article | Year |
|---|---|
[Application of anti-VEGF agents in treatment of neovascular glaucoma and anti-scarring in filtering surgery].
Topics: Aptamers, Nucleotide; Bevacizumab; Cicatrix; Filtering Surgery; Glaucoma, Neovascular; Humans; Ischemia; Ranibizumab; Retinal Vessels; Vascular Endothelial Growth Factor A | 2015 |
Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy.
Topics: Aptamers, Nucleotide; Chemotherapy, Adjuvant; Diabetic Retinopathy; Glaucoma Drainage Implants; Glaucoma, Neovascular; Gonioscopy; Humans; Injections; Iris; Lens Implantation, Intraocular; Male; Middle Aged; Neovascularization, Pathologic; Phacoemulsification; Postoperative Complications; Vitrectomy | 2006 |